Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration. حسب Denis Mustafov (19137870)

"…Microscopic images of colonies were taken at ×40 magnification. The data represents mean values and standard deviation, n = 3. <b>Legends:</b> ns: non-significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.…"

CKO mice display decreased skin barrier function and perturbed homeostasis. حسب Kevin J. Mills (9270966)

الموضوعات:

Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations. حسب Denis Mustafov (19137870)

"…Microscopic images were captured at ×40 magnification. Data represent mean values ± standard deviation, n = 3. <b>Legends:</b> ns: non-significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.…"

Decreased expression of tight junction proteins and disruption of intestinal barrier integrity in DSS-induced colitis mouse model. حسب Mariam Wed Eladham (21439745)

Elevated concentrations of serum MMA among participants with decreased cognitive performance. حسب Yige Liu (11940344)

BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells. حسب Luqiong Liu (11537092)

Madrasin decreases transcription of protein-coding genes. حسب Michael Tellier (8284752)

Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers. حسب Luqiong Liu (11537092)

"…The values are expressed as the means ± SDs and were analyzed according to the variance of the factorial design. **, *** and ****denote <i>p</i> < 0.01, < 0.001 and < 0.0001, respectively; ns  =  not significant.…"

Y-27632 synergized with BA to alleviate the decrease in the expression of and abnormal localization of ZO-1 and Occludin in LPS-induced Caco2 cells. حسب Luqiong Liu (11537092)

Most significant muscle activation values. حسب María Benito-de-Pedro (22057468)

الموضوعات:

Maximum IFN concentrations are decreased in severe patients. حسب Sonia T. Gazeau (21512764)

Annual treatment frequencies in recurrence and non-recurrence groups. حسب Yasuyuki Sotani (20114144)

الموضوعات:

Significant repeated measurements sEMG outcomes. حسب María Benito-de-Pedro (22057468)

الموضوعات:

Significant single measurement sEMG outcomes. حسب María Benito-de-Pedro (22057468)

الموضوعات:

Annual number of outpatient visits in recurrence and non-recurrence groups. حسب Yasuyuki Sotani (20114144)

الموضوعات:

Time course of central retinal thickness (CRT) in recurrence and non-recurrence groups. حسب Yasuyuki Sotani (20114144)

الموضوعات:

Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups. حسب Yasuyuki Sotani (20114144)

الموضوعات:

Time course of optical coherence tomography and fundus findings in a representative non-recurrent eye. حسب Yasuyuki Sotani (20114144)

الموضوعات:

Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year. حسب Mingee Choi (15250732)

الموضوعات:

Lipidomic analysis of epidermis using LC-IMS-CID-MS reveals major changes in CKO// epidermis. حسب Kevin J. Mills (9270966)

الموضوعات: